comunicato stampa
Ichnos Sciences Appoints Sonia Quaratino, M.D., Ph.D., To Its Board Of Directors
NEW YORK, Nov. 9, 2021 /PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative biologics in oncology and autoimmune diseases, announced that Sonia Quaratino, M.D., Ph.D., has been appointed as an independent member of its Board of Directors. Dr. Quaratino has over twenty-five years of experience in immunology research, clinical development at biotechnology and pharmaceutical companies, has served on multiple boards, and overseen research programs at leading acad...
